Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.56 |
| ▸ | DRD1 | P21728 | 1/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.56 |
| ▸ | DRD3 | P35462 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.56 |
| ▸ | EYA2 | O00167 | 1/20 | 0.52 |
| ▸ | APP | P05067 | 1/20 | 0.52 |
| ▸ | ACE | P12821 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20997750 | 0.98 | TDP1 (0.54) | TDP1BLMPMP22ALOX15TSHR | |
| SCHEMBL22766987 | 0.98 | TDP1 (0.54) | TDP1BLMPMP22ALOX15TSHR | |
| SCHEMBL29319565 | 0.96 | TDP1 (0.52) | TDP1BLMPMP22ALOX15TSHR | |
| SCHEMBL13510839 | 0.92 | TDP1 (0.56) | TDP1BLMPMP22ALOX15TSHR | |
| SCHEMBL9387759 | 0.91 | TDP1 (0.56) | TDP1BLMPMP22ALOX15TSHR | |
| SCHEMBL14823493 | 0.91 | TDP1 (0.67) | TDP1BLMPMP22ALOX15TSHR | |
| SCHEMBL12417263 | 0.89 | TDP1 (0.54) | TDP1BLMPMP22ALOX15TSHR | |
| SCHEMBL24177003 | 0.89 | TDP1 (0.71) | TDP1BLMPMP22ALOX15TSHR | |
| SCHEMBL13059960 | 0.89 | TDP1 (0.71) | TDP1BLMPMP22ALOX15TSHR | |
| SCHEMBL1102344 | 0.89 | TDP1 (0.70) | TDP1BLMPMP22ALOX15TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212549-A1 | COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2023-07-06 | — | — | US | disclosed |
| US-20170258945-A1 | LANTHANIDE COMPLEX FORMULATIONS | GE HEALTHCARE AS (GB) | 2017-09-14 | — | — | US | disclosed |
| US-9550704-B2 | Method for synthesizing radiopharmaceuticals using a cartridge | FUTURECHEM CO., LTD. (KR) | 2017-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212549-A1 | COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | FIBP, FN1, TPX2 | TDP1 3724/4885BLM 1576/4885PMP22 4019/4885 |
| US-20170258945-A1 | LANTHANIDE COMPLEX FORMULATIONS | SLC39A14, ORAI1, SARAF | TDP1 3833/4885BLM 3542/4885PMP22 3944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.